TY - JOUR
T1 - Design and rationale of the HAPIN study
T2 - A multicountry randomized controlled trial to assess the effect of liquefied petroleum gas stove and continuous fuel distribution
AU - HAPIN investigators
AU - Clasen, Thomas
AU - Checkley, William
AU - Peel, Jennifer L.
AU - Balakrishnan, Kalpana
AU - McCracken, John P.
AU - Rosa, Ghislaine
AU - Thompson, Lisa M.
AU - Barr, Dana Boyd
AU - Clark, Maggie L.
AU - Johnson, Michael A.
AU - Waller, Lance A.
AU - Jaacks, Lindsay M.
AU - Steenland, Kyle
AU - Miranda, J. Jaime
AU - Chang, Howard H.
AU - Kim, Dong Yun
AU - McCollum, Eric D.
AU - Davila-Roman, Victor G.
AU - Papageorghiou, Aris
AU - Rosenthal, Joshua P.
N1 - Funding Information:
The trial is led by a steering committee composed of the study’s multiple principal investigators (MPIs), the lead investigators of each of the international research centers, the directors of the biomarker core, one NIH project officer, one NIH scientific officer, and one representative of the Bill and Melinda Gates Foundation (BMGF). The steering committee obtains guidance on particular areas of expertise from five study cores (behavior and economics, exposure, clinical and imaging, biomarkers, and data management) and two working groups (pneumonia; anthropometry and nutrition). Day-to-day management of the trial is led by the trial coordinating center, based at Emory. The steering committee is supported by an external advisory committee and the pneumonia working group by an outside expert group. A data safety monitoring board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) is responsible for safeguarding the interests of study participants, assessing the safety and efficacy of study procedures, ensuring data quality, and monitoring the over-all conduct of the study.
Funding Information:
The HAPIN trial is funded by the NIH (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation (OPP1131279). Participating NIH organizations include the NHLBI; National Institute of Environmental Health Sciences (NIEHS); National Cancer Institute (NCI); National Institute of Child Health and Human Development (NICHD); Fogarty International Center (FIC); and the NIH Common Fund. The study protocol has been reviewed and approved by institutional review boards or ethics committees at Emory University (00089799), Johns Hopkins University (00007403), Sri Ramachandra Institute of Higher Education and Research (IECN1/16/JUL/54/49) and the Indian Council of Medical Research? Health Ministry Screening Committee [5/8/4-30/(Env)/Indo-US/ 2016-NCD-I], Universidad del Valle de Guatemala (146-08-2016/ 11-2016) and Guatemalan Ministry of Health National Ethics Committee (11-2016), Asociacion Benefica PRISMA (CE2981.17), London School of Hygiene and Tropical Medicine (11664-5), Rwandan National Ethics Committee (No. 357/RNEC/2018), and Washington University in St. Louis (201611159). The study has been registered with ClinicalTrials.gov (NCT02944682). A multidisciplinary, independent Data and Safety Monitoring Board (DSMB) appointed by the National Heart, Lung, and Blood Institute (NHLBI) monitors the quality of the data and protects the safety of patients enrolled in the HAPIN trial. NHLBI DSMB: N.R. Cook, S. Hecht, C. Karr, J. Millum, N. Sathiakumar (Chair), P.K. Whelton, G.G. Weinmann (Executive Secretary). Program Coordination: G. Rodgers, Bill & Melinda Gates Foundation; C.L. Thompson, National Institute of Environmental Health Science; M.J. Parascandola, National Cancer Institute; D.M. Krotoski and M. Koso-Thomas, Eunice Kennedy Shriver National Institute of Child Health and Human Development; J.P. Rosenthal, Fogarty International Center; C.R. Nierras, NIH Office of Strategic Coordination Common Fund; K. Kavounis, D.Y. Kim, A. Punturieri, and B.S. Schmetter, NHLBI. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. National Institutes of Health or Department of Health and Human Services.
Funding Information:
The HAPIN trial is funded by the NIH (cooperative agreement 1UM1HL134590) in collaboration with the Bill & Melinda Gates Foundation (OPP1131279). Participating NIH organizations include the NHLBI; National Institute of Environmental Health Sciences (NIEHS); National Cancer Institute (NCI); National Institute of Child Health and Human Development (NICHD); Fogarty International Center (FIC); and the NIH Common Fund.
Publisher Copyright:
© 2020, Public Health Services, US Dept of Health and Human Services. All rights reserved.
PY - 2020/4
Y1 - 2020/4
N2 - BACKGROUND: Globally, nearly 3 billion people rely on solid fuels for cooking and heating, the vast majority residing in low-and middle-income countries (LMICs). The resulting household air pollution (HAP) is a leading environmental risk factor, accounting for an estimated 1.6 million premature deaths annually. Previous interventions of cleaner stoves have often failed to reduce exposure to levels that produce meaningful health improvements. There have been no multicountry field trials with liquefied petroleum gas (LPG) stoves, likely the cleanest scalable intervention. OBJECTIVE: This paper describes the design and methods of an ongoing randomized controlled trial (RCT) of LPG stove and fuel distribution in 3,200 households in 4 LMICs (India, Guatemala, Peru, and Rwanda). METHODS: We are enrolling 800 pregnant women at each of the 4 international research centers from households using biomass fuels. We are randomly assigning households to receive LPG stoves, an 18-month supply of free LPG, and behavioral reinforcements to the control arm. The mother is being followed along with her child until the child is 1 year old. Older adult women (40 to <80 years of age) living in the same households are also enrolled and followed during the same period. Primary health outcomes are low birth weight, severe pneumonia incidence, stunting in the child, and high blood pressure (BP) in the older adult woman. Secondary health outcomes are also being assessed. We are assessing stove and fuel use, conducting repeated personal and kitchen exposure assessments of fine particulate matter with aerodynamic diameter ≤2:5 lm (PM2:5), carbon monoxide (CO), and black carbon (BC), and collecting dried blood spots (DBS) and urinary samples for biomarker analysis. Enrollment and data collection began in May 2018 and will continue through August 2021. The trial is registered with ClinicalTrials.gov (NCT02944682). CONCLUSIONS: This study will provide evidence to inform national and global policies on scaling up LPG stove use among vulnerable populations.
AB - BACKGROUND: Globally, nearly 3 billion people rely on solid fuels for cooking and heating, the vast majority residing in low-and middle-income countries (LMICs). The resulting household air pollution (HAP) is a leading environmental risk factor, accounting for an estimated 1.6 million premature deaths annually. Previous interventions of cleaner stoves have often failed to reduce exposure to levels that produce meaningful health improvements. There have been no multicountry field trials with liquefied petroleum gas (LPG) stoves, likely the cleanest scalable intervention. OBJECTIVE: This paper describes the design and methods of an ongoing randomized controlled trial (RCT) of LPG stove and fuel distribution in 3,200 households in 4 LMICs (India, Guatemala, Peru, and Rwanda). METHODS: We are enrolling 800 pregnant women at each of the 4 international research centers from households using biomass fuels. We are randomly assigning households to receive LPG stoves, an 18-month supply of free LPG, and behavioral reinforcements to the control arm. The mother is being followed along with her child until the child is 1 year old. Older adult women (40 to <80 years of age) living in the same households are also enrolled and followed during the same period. Primary health outcomes are low birth weight, severe pneumonia incidence, stunting in the child, and high blood pressure (BP) in the older adult woman. Secondary health outcomes are also being assessed. We are assessing stove and fuel use, conducting repeated personal and kitchen exposure assessments of fine particulate matter with aerodynamic diameter ≤2:5 lm (PM2:5), carbon monoxide (CO), and black carbon (BC), and collecting dried blood spots (DBS) and urinary samples for biomarker analysis. Enrollment and data collection began in May 2018 and will continue through August 2021. The trial is registered with ClinicalTrials.gov (NCT02944682). CONCLUSIONS: This study will provide evidence to inform national and global policies on scaling up LPG stove use among vulnerable populations.
UR - http://www.scopus.com/inward/record.url?scp=85084170479&partnerID=8YFLogxK
U2 - 10.1289/EHP6407
DO - 10.1289/EHP6407
M3 - Article
C2 - 32347766
AN - SCOPUS:85084170479
SN - 0091-6765
VL - 128
JO - Environmental Health Perspectives
JF - Environmental Health Perspectives
IS - 4
M1 - 047008
ER -